baber/WOPTO huggingface dataset:
Patent CA-3170004-A1 (CA)
Inventor: BAO XIAOYING
IPC: C10G35/06
Filed: 2021-02-10
Abstract: Processes for upgrading a hydrocarbon. The process can include contacting a hydrocarbon-containing feed with fluidized catalyst particles that can include a Group 8-10 element or a compound thereof disposed on a support to effect one or more of dehydrogenation, dehydroaromatization, and dehydrocyclization of at least a portion of the hydrocarbon-containing feed to produce a coked catalyst and an effluent. The process can also include contacting at least a portion of the coked catalyst particles with an oxidant to effect combustion of at least a portion of the coke to produce regenerated catalyst particles. The process can also include contacting an additional quantity of the hydrocarbon-containing feed with at least a portion of the regenerated catalyst particles to produce additional effluent and re-coked catalyst particles.
Patent CA-3172883-A1 (CA)
Title: Storage device with movable element
Inventor: MCKENNA SEAN
IPC: A45F3/04
Filed: 2022-09-01
Abstract: In an aspect, a storage device is provided and includes a container including an exterior surface and an opening therethrough. The storage device further includes at least one movable facial feature element. The storage device further includes an actuator operatively connected to the at least one movable facial feature element for driving movement of the at least one movable facial feature element. The storage device further includes a closure structure extending along the opening, and a traveler that is movably mounted to the closure structure for movement between a first traveler position and a second traveler position to open or close the closure structure. A coupling arrangement connects the traveler to the actuator such that movement of the traveler drives movement of the actuator, which in turn drives movement of the at least one movable facial feature element.
Patent CA-3183111-A1 (CA)
Title: Compound for adjusting activity of nmda receptor, and pharmaceutical composition and use thereof
Inventor: GU WEI
IPC: A61P25/22
Filed: 2021-05-12
Abstract: Provided are a compound for adjusting the activity of an NMDA receptor, and a pharmaceutical composition and the use thereof. In particular, provided are a compound as represented by formula I, or a pharmaceutically acceptable salt or ester, a stereoisomer, or a solvate thereof. The compound has the effect of enhancing the activity of the NMDA receptor, and can be used to prepare drugs for preventing/treating depression, anxiety disorder, tension, learning and cognitive defects, neuropathic pain and other diseases.
Patent CA-3187011-A1 (CA)
Title: Sharing location information with a recipient
Inventor: SHROFF SUMEET PRADEEP
IPC: H04W4/40
Filed: 2017-05-19
Abstract: Computer program products, methods, systems, apparatus, and computing entities for tracking an item delivery are provided. In one embodiment, an item is associated with a vehicle (e.g., manned or unmanned terrestrial vehicle, nautical vehicle, and/or aerial vehicle) by updating item data in a database. An item tracking session is then generated based on the item data. Upon the determination that session availability trigger has occurred, access to the item tracking session is provided to a user. Data representing an updated location of the delivery vehicle is then used to update the item data to indicate the current location of the item as the updated location of the vehicle.
Patent CA-3189358-A1 (CA)
Inventor: DURRANT LINDA GILLIAN
IPC: A61K39/215
Filed: 2021-08-25
Abstract: La présente invention concerne des acides nucléiques et des peptides codés par ces acides nucléiques. En particulier, les peptides comprennent une région Fc d'IgG1 modifiée et un ou plusieurs épitopes hétérologues, qui peuvent être des épitopes de lymphocytes B ou T. Un acide nucléique selon l'invention peut coder pour un polypeptide comprenant : (i) une région Fc modifiée d'une IgG1 humaine, et (ii) au moins un antigène hétérologue, (a) la région Fc modifiée comprenant au moins la partie de Fc qui est susceptible de se lier au CD64 et/ou au TRIM21, (b) au moins un résidu de la région Fc étant modifié par rapport au résidu correspondant d'un anticorps IgG3 de souris et (c) la région Fc modifiée présentant une avidité accrue pour le récepteur Fc-gamma (Fc?R) par rapport à la région Fc de type sauvage correspondante.
Patent CA-3189803-A1 (CA)
Inventor: MADDEN DONALD GERARD
IPC: G08B19/00
Filed: 2021-07-21
Abstract: Methods, systems, and apparatus, including computer programs encoded on computer-storage media, for property management and monitoring using a drone. In some implementations, images of an outside area corresponding to a property are obtained. From the images, it is determined that a person is approaching the property. A state of the property is identified. An action to perform by a drone is determined based on the images and a state of the property. The drone is instructed to navigate to the person and perform the action.
Patent CA-3190727-A1 (CA)
Inventor: YE YING
IPC: A61P37/02
Filed: 2021-08-25
Abstract: A method of treating an autoimmune disease such as Sjögren's Syndrome is provided. The method comprises administration of an antibody or an antigen binding portion thereof that specifically binds an epitope of CD40 associated with antagonism. The antibody or the antigen binding portion thereof does not exhibit CD40 agonist activity in either in vitro or in vivo preclinical testing. The antibody inhibits CD40L-induced signaling on DCs, resulting at least in part to reduced production of pro?inflammatory cytokines, and reduction of cell surface activation markers, CD86 and CD54. The antibodies can comprise an Fc region containing a mutation that reduces or eliminates binding to Fc receptors, reducing or eliminating Fc gamma receptor (Fc?R)-mediated cross-linking or clustering.
Patent CA-3191450-A1 (CA)
Inventor: QIAO WEIHUA
Filed: 2023-02-28
Abstract: End-to-end latency measurements for synchronization are described. A first wireless device may determine an uplink latency associated with sending communications to a second wireless device. The first wireless device may determine a downlink latency associated with receiving communications from the second wireless device. Based on the uplink latency being different from the downlink latency, the first wireless device, the second wireless, and/or a base station may perform an alignment (e.g., time-based alignment, channel-based alignment) to modify and/or adjust one or more parameters to make the uplink latency equivalent to the downlink latency.
Patent CA-3193353-A1 (CA)
Title: Recepteurs de lymphocytes t specifiques de prame et leurs utilisations
Inventor: WEHNER CARINA
IPC: C07K14/47
Filed: 2021-09-24
Abstract: La présente invention concerne un récepteur de lymphocytes T (TCR) pouvant se lier à un polypeptide comprenant la séquence d'acides aminés LYVDSLFFL ou une partie de celle-ci ou sa forme de liaison à HLA-A. La présente invention concerne également des molécules d'acide nucléique codant pour ledit TCR, un vecteur comprenant ladite molécule d'acide nucléique, ainsi qu'une cellule hôte comprenant ladite molécule d'acide nucléique ou ledit vecteur. La présente invention concerne en outre des procédés permettant d'obtenir ledit TCR et des compositions pharmaceutiques et diagnostiques comprenant ledit TCR, ladite molécule d'acide nucléique, vecteur et/ou cellule hôte. La présente invention concerne en outre de telles compositions pharmaceutiques et diagnostiques destinées à être utilisées dans le diagnostic, la détection, la prévention et/ou le traitement du cancer. La présente invention concerne par ailleurs l'utilisation dudit TCR, molécule d'acide nucléique, ou dudit vecteur, pour générer des lymphocytes modifiés.
Patent CA-3195064-A1 (CA)
Inventor: EITAN EREZ
IPC: G01N33/543
Filed: 2021-09-14
Abstract: The present invention relates to minimally invasive, biomarker-based diagnostics for neurodegenerative diseases, and to compositions and methods for isolating and analyzing specific populations of extracellular vesicles (EV). In particular, embodiments of the invention relate to methods and systems for isolating, identifying or capturing neuron-derived EV, for analyzing biological samples, and for diagnosing, assessing and predicting the development of neurological and neurodegenerative conditions.
Patent CA-3198024-A1 (CA)
Inventor: ANANDAN SAMPATH KUMAR
IPC: C07D213/81
Filed: 2021-11-11
Abstract: La présente invention concerne des inhibiteurs de HSD17B13 et des compositions pharmaceutiques comprenant lesdits inhibiteurs. Les composés et compositions de l'invention sont utiles pour le traitement d'une maladie hépatique, d'une maladie métabolique ou d'une maladie cardiovasculaire, telle que la NAFLD ou la SHNA, ou la lésion hépatique induite par un médicament (DILI).
Patent CA-3199532-A1 (CA)
Inventor: PORTOLES JOSE
IPC: F16B7/02
Filed: 2020-12-09
Abstract: Attachment device (10, 100) obtained by joining three components (12, 14 or 114, 18 or 118) to the end of a tube (16), comprising: - a conical insert (14, 114) in the form of a truncated cone the diameter of which narrows in the direction of the end of the tube, the conical insert (14, 114) having a receiving element (56), - an internal ring (12) which is provided with a recess (52) in the form of a truncated cone the diameter of which narrows in the direction of the interior of the tube and the angle of which is equal to the angle of the truncated cone of the conical insert, the external wall of the internal ring being cylindrical with a diameter substantially equal to the internal diameter of the tube (16), the insert being located in the recess of the internal ring. According to the main features of the invention, the attachment device comprises an external ring (18, 118) comprising a cylindrical portion the internal diameter of which is substantially equal to the external diameter of the tube, the internal wall of the cylindrical portion of the external ring being intended to come into contact with the cylindrical external wall of the tube (16), the external ring comprising a shoulder (28, 128) which partially closes an end of the external ring and which has a circular opening (38, 138), the shoulder comprising an annular internal face (48, 148) which is intended to abut the end face (26) of the tube (16) and the transverse end face (22) of the internal ring (12) located at the side of the end of the tube. The invention also relates to the method for assembling such an attachment device and the use thereof in the construction of a dirigible.
Patent CA-3200347-A1 (CA)
Title: Interactive interfaces for machine learning model evaluations
Inventor: LEE POLLY PO YEE
IPC: G06F40/00
Filed: 2015-06-30
Abstract: A first data set corresponding to an evaluation run of a model is generated at a machine learning service for display via an interactive interface. The data set includes a prediction quality metric. A target value of an interpretation threshold associated with the model is determined based on a detection of a particular client's interaction with the interface. An indication of a change to the prediction quality metric that results from the selection of the target value may be initiated.
Patent CA-3200507-A1 (CA)
Inventor: PIRI MOHAMMAD
IPC: C09K8/62
Filed: 2021-11-30
Abstract: Des modes de réalisation de la présente divulgation concernent d'une manière générale des procédés et des formulations pour une récupération assistée du pétrole. Selon un mode de réalisation, un procédé de traitement de milieux poreux contenant du pétrole pour la récupération du pétrole consiste à introduire une formulation de tensioactif décrite dans la description dans des milieux poreux contenant du pétrole. Des procédés peuvent être utilisés pour, par exemple, une inversion de la mouillabilité ou une récupération du pétrole. L'invention concerne également des formulations de tensioactifs.
Patent CA-3200763-A1 (CA)
Title: Crispr/cas screening system materials and methods
Inventor: FRODIN MORTEN
IPC: C12N15/10
Filed: 2021-12-03
Abstract: The present disclosure relates to methods for assessing the effects of a mutation of interest in a cell. Herein are also disclosed systems for assessing the effects of a mutation of interest in a cell. The disclosure also provides host cells and host cell populations comprising the system.
Patent CA-3201299-A1 (CA)
Title: Distributeur a pompe recyclable
Inventor: BARTOLUCCI STEFANO
IPC: B05B11/00
Filed: 2021-12-14
Abstract: Un distributeur à pompe dans lequel les ensembles pompes n'ont pas besoin d'être démontés pour être recyclés dans des flux de recyclage actuels. L'ensemble pompe peut comprendre un ressort en plastique qui ne perd pas de rigidité au fil du temps et n'interagit pas avec le produit liquide.
Patent CA-3202837-A1 (CA)
Title: Toy water ball
Inventor: CHEN YUNFENG
IPC: A63H33/18
Filed: 2021-01-20
Abstract: Disclosed is a toy water ball comprising a plurality of petals each having a first edge portion provided with at least one first magnetic member and a second edge portion provided with at least one second magnetic member. When all petals are closed to form a spherical shape, an attraction force is generated between the first magnetic members of each petal and the second magnetic members of the adjacent petal so that the first edge portion of the petal tightly fit the second edge portion of the adjacent petal and a water-carrying cavity is formed. The toy water ball disclosed can be closed or opened repeatedly via cooperation of the first and second magnetic members and can be reused. The toy water ball can also be filled with water in a common water source without a specific pressure.
Patent CA-3204238-A1 (CA)
Inventor: OSBORN KEVIN
IPC: H04W4/80
Filed: 2022-01-26
Abstract: Systems and methods for authentication may include a first device having an association with a first account, including a memory containing one or more applets, a counter value, and transmission data, a communication interface, and one or more processors in communication with the memory and communication interface. The first device may create a cryptogram based on the counter value, wherein the cryptogram includes the counter value and the transmission data. The first device may transmit, after entry of the communication interface into a communication field, the cryptogram, and update, after transmission of the cryptogram, the counter value. The first device may receive, via the communication interface, one or more encrypted keys and one or more parameters. The first device may decrypt the one or more encrypted keys and, after decryption of the one or more encrypted keys, switch an association from the first account to a second account.
Patent CA-3206207-A1 (CA)
Inventor: BOCK SOLENE
IPC: C08B30/12
Filed: 2022-02-04
Abstract: L'invention est relative à un amidon thermiquement modifié produit par voie acide, caractérisé en ce qu'il présente un taux de citrate libre inférieur à 0,05 % et un taux de citrate fixé compris entre 0,05 et 0,15 %, une température au maximum de gonflement des grains d'amidon, analysée au RVA entre 2 et 17 minutes, supérieure à 100°C, de préférence comprise entre 100 et 140°C, et/ou un volume de sédimentation compris entre 20 et 65 ml, de préférence entre 25 et 40 ml.
Patent CA-3208122-A1 (CA)
Inventor: BUCHER CHRISTOPH
IPC: A61K31/00
Filed: 2022-01-27
Abstract: La présente invention concerne des modulateurs du récepteur S1P, de préférence le mocravimod, destinés à être utilisés dans le traitement de patients souffrant de leucémie myéloïde aiguë (LMA) et qui ont subi une transplantation de cellules souches hématopoïétiques allogéniques (TCSH). L'invention concerne en particulier des procédés de traitement de la leucémie myéloïde aiguë (LMA) chez des sujets subissant une TCSH, ledit procédé comprenant l'administration quotidienne d'une quantité efficace de modulateur du récepteur S1P, de préférence du mocravimod, audit sujet en ayant besoin, pendant au moins 6 mois, de préférence au moins 12 mois.
Patent CA-3218113-A1 (CA)
Title: Traitement de maladies et de troubles pulmonaires et respiratoires
Inventor: HILL DEREK
IPC: A61K35/42
Filed: 2022-05-04
Abstract: Un aérosol contenant de fines gouttelettes, les gouttelettes contenant séparément ou ensemble un premier composant comprenant une préparation aqueuse d'un métal de transition ou d'un composé associé et un second composant qui est une préparation aqueuse contenant au moins un composé d'augmentation du potentiel d'oxydo-réduction tel que le chlorite, est utile dans la lutte contre les troubles et les maladies respiratoires provoqués par des pathogènes tels que la grippe, le RSV et le coronavirus, ainsi que des infections bactériennes seules ou associées à un pathogène viral.
Patent CA-3218886-A1 (CA)
Inventor: JIANG QI
IPC: B01J41/07
Filed: 2021-05-19
Abstract: L'invention concerne des procédés de purification d'éthers de glycol, comprenant (a) la fourniture d'un éther de glycol à un premier récipient, l'éther de glycol, l'éther de glycol ayant la formule suivante : R 1-O- (CHR 2CHR 3) O) nR 4 ; dans laquelle R 1 représente un groupe alkyle ayant 1 à 9 atomes de carbone ou un groupe phényle ; dans laquelle R 2 et R 3 représentent chacun individuellement un atome d'hydrogène, un groupe méthyle ou un groupe éthyle, à condition que lorsque R 3 représente un groupe méthyle ou un groupe éthyle, R 2 représente un atome d'hydrogène et à condition que lorsque R 2 représente un groupe méthyle ou un groupe éthyle, R 3 représente l'hydrogène ; dans laquelle R 4 représente un atome d'hydrogène, un groupe alkyle ayant 1 à 4 atomes de carbone, un groupe acétyle ou un groupe propionyle ; et n étant un nombre entier de 1 à 3 ; (b) le remplissage du premier récipient avec un gaz inerte ; (c) le chauffage de l'éther de glycol dans le premier récipient à une température inférieure à l'ébullition, la température inférieure à l'ébullition étant d'au moins 15 °C inférieure au point d'ébullition normal de l'éther de glycol ; (d) le refroidissement de la vapeur du premier récipient dans un second récipient pour fournir un liquide ; et (e) la mise en contact l'éther de glycol avec un lit mélangé de résines échangeuses d'ions comprenant des résines d'échangeuses de cations et des résines échangeuses d'ions anioniques.
Patent CA-3220251-A1 (CA)
Inventor: UENER AHMET
IPC: C02F5/14
Filed: 2022-05-23
Abstract: The invention relates to the use of an aqueous solution of acrylic acid polymer for inhibiting scale formation in a desalination system, wherein the polymer of acrylic acid obtained by a process of polymerising acrylic acid in feed operation with a free radical starter in the presence of hypophosphite in water as solvent, which comprises (i) initially charging water and aqueous hypophosphite solution and optionally acrylic acid in acidic, unneutralised form, optionally one or more ethylenically unsaturated comonomers, and optionally initiator, (ii) adding acrylic acid in acidic, unneutralised form, optionally one or more ethylenically unsaturated comonomers, aqueous free radical starter solution and aqueous hypophosphite solution, (iii) adding a base to the aqueous solution after termination of the acrylic acid feed, wherein the comonomer content does not exceed 30 wt. % based on the total monomer content, wherein the acrylic acid, the aqueous free radical starter solution and the aqueous hypophosphite solution are added such that the molar ratio x of acrylic acid to phosphorus-bound hydrogen [AA]/[P-H] over a time period in which at least 75% of the acrylic acid is converted and has a value x which is constant to within ± 0.5 and is in the range from 0.8 to 2, wherein the acrylic acid polymer has a weight average molecular mass Mw of from 1000 to 3000 g/mol, wherein the desalination system comprises at least one of the group consisting of Multi Stage Flash (MSF), at least one Multi Effect Distillation (MED) and Reverse Osmosis (RO). The invention also relates to a process of desalinating saline water in a desalination system.
Patent WO-9220209-A1 (WO)
Title: Compost processing tool
Inventor: SAINSBURY J DOUGLAS
IPC: C05F17/02
Filed: 1991-08-15
Abstract: The present invention is directed to a compost processing tool (2) having a blade (4) at one end thereof suitable for chopping, cutting and turning compost (50). The tool (2) also includes a hollow shaft (6) extending from the blade (4) with the shaft (6) having a host of openings (8) through a wall of the shaft (6) with the holes (8) spaced in the length of the shaft (6). This hollow shaft (6) may be used to provide a lever for the blade (4) used during chopping, cutting and turning of the compost (50) and the shaft (6) also serves as a breather tube when placed in a volume of compost (50) with the shaft (6) partially buried in the compost (50).
Patent WO-9312391-A1 (WO)
Title: Humidifier
Inventor: PENNO HARRY
IPC: B01F7/02
Filed: 1992-10-09
Abstract: A humidifier includes a rotating circular base plate (12) driven by a motor (30) through a gear reduction mechanism (28). A plurality of elongated troughs (14) are mounted in a spaced circular array adjacent a periphery of the base plate (12), such that outer edges of the trough (14) are disposed on the surface of a cylinder. A centrally disposed drive shaft (18) extends axially from the base plate (12) and includes a plurality of radially extending circumferentially spaced fins (20, 22, 24, 26). The rotating base plate (12) and attached troughs (14) are mounted in a housing (32) having an inlet duct (42) and an outlet duct (44) connected in a cold air return duct of a conventional forced air type furnace. A water tank (34) disposed in the bottom of the housing is connected by a float valve (38) to a water supply source (36) such that a constant water level is maintained in the tank. As the base plate (12) rotates, the troughs (14) scoop off water, carry it upwardly into the air flow path, and gradually spill the water to create a waterfall in the air flow path. The radial fins (20, 22, 24, 26) on the drive shaft (18) create turbulence in the air flow patch to maximize the amount of moisture entrained in the air flow stream.
Patent WO-9407294-A1 (WO)
Inventor: NOR JIRI K
IPC: H02J7/00
Filed: 1993-07-14
Abstract: Un chargeur pour éléments ou pour batteries rechargeables ou pour batteries utilise un mécanisme dans lequel la tension sans résistance est surveillée de manière continue pendant des interruptions périodiques du processus de charge et comparée avec une tension de référence indépendante pour éviter la surcharge. Après qu'un certain niveau de charge ait été obtenu, le courant est graduellement réduit à un niveau de finition. Plusieurs dispositifs sont prévus pour achever la charge de finition en évitant la surcharge. Une autre version du chargeur est conçue pour mesurer la tension sans résistance pendant la période de coupure après un temps suffisant permettant la recombinaison de tout l'oxygène ayant été produit pendant la charge, prenant ainsi en compte les variations inhérentes dans les éléments de même type.
Patent WO-9420528-A1 (WO)
Inventor: DEZIEL ROBERT
IPC: A61K38/00
Filed: 1994-02-28
Abstract: On décrit ici des dérivés peptidiques de la formule A-B-D-NHCH{CH2C(O)R1}C(O)-NHCH{CR2(R3)-COOH}C(O)-E, dans laquelle A est un alcanoyle inférieur portant deux substituants, chaque substituant étant choisi d'une manière indépendante dans le groupe constitué de phényle et de phényle monosubstitué, où le monosubstituant étant un alkyle, un halo, un hydroxy ou un alcoxy; B est un reste d'acide aminé N-méthyle; D est un reste d'acide aminé; R1 est un alkyle, un cycloalkyle, un amino monosubstitué ou un amino disubstitué; R2 est hydrogène ou alkyle et R3 est alkyle, ou R2 et R3 sont réunis pour former un cycloalkyle; et E est une unité terminale, par exemple un alkylamino ou un radical monovalent d'acide aminé tel que NHCH(alkyl)C(O)OH. Lesdits dérivés sont utiles pour traiter les infections par l'herpès.